Evidence map›Paper›PMID 32956545›Full record

ReviewChemistry (Weinheim an der Bergstrasse, Germany)2020

Antivitamins B

Bernhard Kräutler

Open access · hybridAbstract readReview
In one paragraph

Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Meso-fluorinated cobalamins: insights into synthesis and redox properties.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Article
  4. Article
  5. Review
  6. Novel Method for the Synthesis of Hydroxycobalamin[International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antivitamins BChemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Bernhard KräutlerInstitute of Organic Chemistry and Center for Molecular Biosciences (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-2222-0587
Universität Innsbruck · AT

Funding

Austrian Science Fund P-28892Austrian Science Fund P-30359Austrian Science Fund FWF P 28892Austrian Science Fund FWF P 33059
6 · The paper itself

Abstract

The recently delineated structure- and reactivity-based concept of antivitamins B

Indexed as

AntimetabolitesVitamin B 12AnimalsHumansNeoplasmsVitaminsAntimetabolitesVitamin B 12Vitaminsantibioticcobalamingrowth inhibitortransition metalvitamin

Identifiers

PMID32956545
PMCPMC7756841
OpenAlexW3087345608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.